PMID: BMC Complement Med Ther. 2022 Apr 2; 22 (1): 98. Epub 2022 Apr 2. PMID: 35366855 Abstract Title: Hesperidin identified from Citrus extracts potently inhibits HCV genotype 3a NS3 protease. Abstract: BACKGROUND: Hepatitis C virus infection is the main cause of liver ailments across the globe. Several HCV genotypes have been identified in different … Read more
PMID: Front Pharmacol. 2022; 13: 856410. Epub 2022 Apr 26. PMID: 35559249 Abstract Title: For the Long-Term Prevention of Viral Respiratory Tract Infections During Covid-19 Pandemic: A Randomized, Open, Controlled, Exploratory Clinical Study. Abstract: SARS-CoV-2 vaccination is effective in preventing severe Covid-19, but efficacy in reducing viral load and transmission wanes over time. In addition, … Read more
PMID: Front Oncol. 2022; 12: 837408. Epub 2022 May 18. PMID: 35664773 Abstract Title: Prospective Medicinal Plants and Their Phytochemicals Shielding Autoimmune and Cancer Patients Against the SARS-CoV-2 Pandemic: A Special Focus on Matcha. Abstract: Background: Being "positive" has been one of the most frustrating words anyone could hear since the end of 2019. This … Read more
PMID: RSC Adv. 2021 Sep 1; 11 (47): 29267-29286. Epub 2021 Sep 1. PMID: 35492070 Abstract Title: Anti-SARS-CoV-2 activities of tanshinone IIA, carnosic acid, rosmarinic acid, salvianolic acid, baicalein, and glycyrrhetinic acid between computational andinsights. Abstract: Six compounds namely, tanshinone IIA (1), carnosic acid (2), rosmarinic acid (3), salvianolic acid B (4), baicalein (5), and … Read more
PMID: J Food Biochem. 2022 Jan 19: e14062. Epub 2022 Jan 19. PMID: 35043973 Abstract Title: Phytoconstituents from Moringa oleifera fruits target ACE2 and open spike glycoprotein to combat SARS-CoV-2: An integrative phytochemical and computational approach. Abstract: Therapeutic drugs based on natural products for the treatment of SARS-CoV-2 are currently unavailable. This study was conducted … Read more